GlassScriptPhysician profile
Avinash L Jadhav
NPI 1447211545
$17,321.83
in general payments reported to CMS, 2019-2025
27 companies · $507 in 2025
The $507 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,685 · 2020: $3,747 · 2021: $2,185 · 2022: $2,504 · 2023: $1,312 · 2024: $2,382 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,835 · Travel and Lodging: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,835.13 |
| Travel and Lodging | $1,366.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,902.08 | 2019-2024 | |
| Stryker Corporation | $4,851.54 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Pangea |
| Smith+Nephew, INC. | $855.80 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $837.81 | 2020-2024 | |
| Coastal Medical Technologies LLC | $706.36 | 2023-2025 | |
| Medical Device Business Services, INC. | $489.68 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $207.19 | 2023 | Iovera |
| Uoc USA INC | $187.76 | 2025 | U-Star, Conformity, U2 |
| Globus Medical, INC. | $187.64 | 2019-2021 | |
| Encore Medical, LP | $142.09 | 2019-2024 | Djo Surgical |
| Depuy Synthes Sales INC. | $137.95 | 2019-2023 | Na |
| Acelrx Pharmaceuticals, INC. | $120.02 | 2021 | |
| Exactech, INC. | $114.91 | 2021 | |
| Maxx Orthopedics, INC. | $88.74 | 2022 | |
| Sanara Medtech INC. | $75.26 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $73.81 | 2020 | |
| Think Surgical, INC. | $61.49 | 2023 | |
| Organogenesis INC. | $54.96 | 2021 | |
| Omnilife Science, INC | $49.12 | 2023 | Omnibotics 3.0 |
| Mimedx Group, INC. | $37.25 | 2025 | |
| Bioventus LLC | $26.11 | 2020-2025 | Xcell |
| Orthofix Medical, INC. | $24.71 | 2024 | Physio-Stim |
| Mvp Orthopedics INC | $22.01 | 2022 | |
| Kerecis Limited | $18.97 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $18.11 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Fidia Pharma USA INC. | $16.79 | 2022 | |
| Endo Pharmaceuticals INC. | $13.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Jadhav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.